Kyung NAM Pharm

경남제약 · 053950

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$24.5M (₩33.8B)

Overview

Kyung NAM Pharm makes everyday consumer health products, most notably Lemona, a powdered vitamin supplement, alongside over-the-counter medicines, a placenta-based health drink, a throat-infection treatment, and an antifungal remedy.

Its products reach consumers through tens of thousands of pharmacies nationwide, as well as convenience stores, large supermarkets, and health-and-beauty retailers. Listed on KOSDAQ, Korea's small-cap board, the company earns the largest share of its revenue from its over-the-counter medicines segment, with general food and health-functional food lines making up most of the remainder.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$40.5M
▼ −8.0% YoY
Operating profit · FY2025
−US$1.3M
Loss widened
Net income · FY2025
−US$6.5M
Turned to loss

Revenue

  • FY2023US$49.6M
  • FY2024US$44.1M
  • FY2025US$40.5M

Operating profit

  • FY2023−US$4.9M
  • FY2024−US$683.2K
  • FY2025−US$1.3M

Net income

  • FY2023−US$16.1M
  • FY2024US$6.3M
  • FY2025−US$6.5M

Key ratios (FY2025)

ROE
-8.3%
Debt/Eq
43.7%
Op. margin
-3.1%
Net margin
-16.1%
Rev. YoY
▼ −8.0%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.